日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Stress-Programmed Immune Niches Fuel TNFR2+ Treg Activation and Drive Neoadjuvant Chemotherapy Resistance in Breast Cancer.

应激编程的免疫微环境促进 TNFR2+ Treg 激活,并驱动乳腺癌新辅助化疗耐药性。

Shao Zhibo, Wang Xuliren, Zhu Han, Yao Ling, Zhang Qi, Zhai Zihan, Lv Xinyi, Xia Xinyuan, Zhang Yi, Lu Xinya, Quan Xinyi, Yang Jiawen, Li Xinwei, Dong Jieyi, Shao Zhi-Ming, Wang Ruoxi, Xiu Bingqiu, Wu Jiong, Chen Sheng

MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway

MSMO1通过PERK/eIF2α/ATF4/CHOP通路调控T-MAS代谢,从而促进化疗耐药。

Ren, Hengyu; Wang, Xuliren; Shao, Zhibo; Xiong, Min; Chi, Weiru; Sang, Yuting; Zhang, Qi; Wang, Zehao; Liu, Douwaner; Zhang, Liyi; Chen, Ming; Zhu, Han; Xue, Jingyan; Xiu, Bingqiu; Chi, Yayun; Wu, Jiong

Current Trends in Revision Surgery After Breast Reconstruction in China: Insights from a Nationwide Cross-Sectional Survey

中国乳房重建术后翻修手术的现状:一项全国性横断面调查的启示

Zhang, Yi; Zhang, Qi; Chen, Yiding; Hao, Shuang; Yang, Benlong; Zhang, Yingying; Wang, Xuliren; Shao, Zhibo; Zhu, Han; Xiu, Bingqiu; Wu, Jiong

Shifting Practice Patterns in Implant-based Breast Reconstruction in China: Insights From a 13-year Large-scale Retrospective Cohort

中国基于植入物的乳房重建实践模式转变:一项为期13年的大型回顾性队列研究的启示

Shao, Zhibo; Wang, Xuliren; Zhang, Qi; Zhu, Han; Zhang, Yi; Lu, Xinya; Chen, Jiajian; Zhang, Yingying; Cao, Ayong; Mo, Miao; Shao, Zhi-Ming; Xiu, Bingqiu; Hao, Shuang; Wu, Jiong

Lysine vitcylation is a vitamin C-derived protein modification that enhances STAT1-mediated immune response.

赖氨酸维生素C化是一种维生素C衍生的蛋白质修饰,可增强STAT1介导的免疫反应

He Xiadi, Wang Qiwei, Cheng Xin, Wang Weihua, Li Yutong, Nan Yabing, Wu Jiang, Xiu Bingqiu, Jiang Tao, Bergholz Johann S, Gu Hao, Chen Fuhui, Fan Guangjian, Sun Lianhui, Xie Shaozhen, Zou Junjie, Lin Sheng, Wei Yun, Lee James, Asara John M, Zhang Ke, Cantley Lewis C, Zhao Jean J

LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast Cancer.

LINC01235 通过 DNA 复制许可诱导的染色体不稳定性促进乳腺癌的克隆进化

Zhang Qi, Wang Xuliren, Shao Zhibo, Zhang Yi, Zhang Liyi, Chen Ming, Zhou Xujie, Zhu Han, Zhou Yue, Lu Xinya, Li Pei, Chi Weiru, Li Lun, Shao Zhi-Ming, Huang Shenglin, Xue Jingyan, Chi Yayun, Wu Jiong, Xiu Bingqiu

PPARG Activation of Fatty Acid Metabolism Drives Resistance to Anti-HER2 Therapies in HER2-Positive Breast Cancer

PPARG激活脂肪酸代谢驱动HER2阳性乳腺癌对HER2抑制剂的耐药性

Xiong, Min; Liu, Douwaner; Wang, Xuliren; Ren, Hengyu; Chi, Weiru; Xiu, Bingqiu; Zhang, Qi; Zhang, Jiayu; Zhang, Liyi; Wang, Zehao; Chen, Ming; Xue, Jingyan; Chi, Yayun; Wu, Jiong

JCAD-Derived from Plasma Exosomes: Promoting Tumor Cell Progression and Predicting Poor Outcomes in Breast Cancer

源自血浆外泌体的JCAD:促进肿瘤细胞进展并预测乳腺癌不良预后

Liu, Douwaner; Xiong, Min; Chen, Xiaoting; Wang, Xuliren; Sang, Yuting; Liu, Shiyang; Zhang, Liyi; Chi, Weiru; Ren, Hengyu; Xiu, Bingqiu; Zhang, Qi; Chi, Yayun; Wu, Jiong; Xue, Jingyan

Comprehensive Pan-Cancer Analysis of RAC1 Decoding the Impact on Cancer Prognosis and B cell immune Regulation.

RAC1 的泛癌综合分析:解码其对癌症预后和 B 细胞免疫调节的影响

Shao Zhibo, Ren Hengyu, Wang Xuliren, Zhang Qi, Xue Jingyan, Chi Yayun, Xiu Bingqiu, Wu Jiong

Evolving Trends in Postmastectomy Breast Reconstruction With Autologous Tissues: A Large-Scale, 24-Year Retrospective Study in China

中国自体组织乳房切除术后重建的演变趋势:一项大规模、为期24年的回顾性研究

Wang, Xuliren; Shao, Zhibo; Zhu, Han; Zhang, Qi; Chen, Jiajian; Zhang, Yingying; Cao, Ayong; Zhang, Yi; Xu, Rui; Xue, Jingyan; Liu, Jing; Mo, Miao; Shao, Zhi-Ming; Xiu, Bingqiu; Wu, Jiong; Hao, Shuang